Back to News
Market Impact: 0.15
Insilico Medicine Opens AI Longevity Discovery Toolkit to Researchers Worldwide in Cell Cover Study
Source: PR Newswire
Artificial IntelligenceHealthcare & BiotechTechnology & Innovation
The paper introduces three interconnected resources for aging-biology research, led by LongevityBench, described as the first open benchmark for rigorously evaluating AI reasoning across multiple aging domains. It also presents Longevity-LLMs, a family of compact open-source language models, aiming to provide the scientific community with accessible AI tools for longevity research. The announcement is positive for open AI-enabled biotech research but is unlikely to have immediate broad market impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Australia’s central bank chief warns inflation risks materialising
- This AI-picked stock jumps 18% on Amazon’s $8 billion power deal
- Asian stocks rise as oil retreat eases inflation fears, BOJ in focus
- California AG Bonta on Paramount-Warner Bros., Meta and AI
- A breakout in the 10-year Treasury yield could hold back stocks if it reaches this level
- Fed rate decision and Warsh comments roiled markets. Where to find opportunities